All lobbying filings

Hance Scarborough

Hance Scarborough filed a Q1 report for Boehringer Ingelheim USA Corporation on April 18, 2026, reporting $20,000 in lobbying income.

Lobbying for Boehringer Ingelheim USA Corporation · Pharmaceutical Company

As filed: HANCE SCARBOROUGH for BOEHRINGER INGELHEIM USA CORPORATION.

All filings by Hance Scarborough · Everything Boehringer Ingelheim USA Corporation has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Animals

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill. USDA Texas New World screw worm facility and eradication.

Pharmacy

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill

Agriculture

National Animal Disease Preparedness and Response Program, and the National Animal Vaccine and Veterinary Countermeasures Vaccine Bank. Farm Bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.